Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Greenwave Technology Solutions (GWAV) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Greenwave Technology Solutions (GWAV) over the last 12 years, with Q2 2025 value amounting to $5.3 million.

  • Greenwave Technology Solutions' Cash & Equivalents fell 7822.53% to $5.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $5.3 million, marking a year-over-year decrease of 7822.53%. This contributed to the annual value of $2.6 million for FY2024, which is 6663.64% up from last year.
  • As of Q2 2025, Greenwave Technology Solutions' Cash & Equivalents stood at $5.3 million, which was down 7822.53% from $5.5 million recorded in Q1 2025.
  • Greenwave Technology Solutions' 5-year Cash & Equivalents high stood at $24.3 million for Q2 2024, and its period low was $204.0 during Q1 2021.
  • In the last 5 years, Greenwave Technology Solutions' Cash & Equivalents had a median value of $1.5 million in 2023 and averaged $3.6 million.
  • In the last 5 years, Greenwave Technology Solutions' Cash & Equivalents skyrocketed by 87748039.22% in 2022 and then tumbled by 8457.85% in 2023.
  • Greenwave Technology Solutions' Cash & Equivalents (Quarter) stood at $3.0 million in 2021, then plummeted by 72.22% to $821804.0 in 2022, then soared by 88.14% to $1.5 million in 2023, then soared by 66.64% to $2.6 million in 2024, then soared by 105.39% to $5.3 million in 2025.
  • Its Cash & Equivalents stands at $5.3 million for Q2 2025, versus $5.5 million for Q1 2025 and $2.6 million for Q4 2024.